SOPHiA GENETICS SA (SOPH)

Every figure this model derived for SOPH, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 574,000 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 70,289,000 CashAndCashEquivalents 2025-12-31
current assets 99,079,000 CurrentAssets 2025-12-31
current liabilities 50,528,000 CurrentLiabilities 2025-12-31
equity 47,145,000 Equity 2025-12-31
interest expense 4,554,000 InterestExpense 2025-12-31
ocf -35,893,000 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 77,271,000 RevenueFromContractsWithCustomers 2025-12-31
sbc 93,657,000 ExpenseFromSharebasedPaymentTransactionsWithEmployees 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up SOPH on one particular measure came for.

RatioValue
cash operating margin34.59
current ratio1.96
current ratio reported1.96
dilution pct2.24
fcf margin-47.19
growth cv0.57
interest cover-15.57
operating margin-91.76
owner earnings margin-168.4
revenue growth18.56
revenue growth per share15.97
roic-140.47
rule of 40-73.2
sbc pct revenue121.21

What to be careful about

What this model itself distrusts about SOPH's figures. Written by the derivation as it ran, not added afterwards.